Post by Morrissette Entrepreneurship

PurelyBiome is a precision skincare platform that uses at-home DNA testing and proprietary AI to eliminate skin care guesswork. By sequencing an individual’s facial microbiome and benchmarking it against 40,000+ clinical studies, the platform identifies the biological root of concerns like acne, sensitivity, and aging and delivers brand-agnostic ingredient and product recommendations while generating high-resolution microbiome intelligence for industry partners. PurelyBiome's Co-founders, Tony Xu, BESc'23, HBA '23, and Michael Wang just completed the Western Accelerator and will be pitching to investors at June's Western Angels' Demo Day. Wang is a specialist in genetics and translational research who transforms complex biotechnology into scalable operations. Formerly a researcher at the University of Toronto, his work on cardiac gene regulation contributed to a sepsis therapeutic now being acquired by Moderna. Wang serves as the scientific and operational lead, having personally engineered PurelyBiome’s end-to-end laboratory protocols, automated sequencing workflows, and the entire pilot infrastructure. Xu turns research into real-world systems. With experience in academia, defense research, and systematic trading at a hedge fund, he has expertise in building scalable AI-grounded solutions and leads software and AI development at PurelyBiome.